Arsenal Capital-backed CellCarta buys Reveal Biosciences

Montreal-based CellCarta, formerly Caprion-HistoGeneX, has acquired Reveal Biosciences, a San Diego, California-based computational pathology company.

ByIris Dorbian

11 May 2021•2 mins read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.

Deals Canada North America US Healthcare Briefs

Arsenal Capital-backed CellCarta buys Reveal Biosciences

Arsenal Capital Partners

Intel Capital

PP Capital

Related articles